Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells

Human Cell

Volumn 25, Issue 2, 2012, Pages 29-35

  Liu, Shutai ^a,b   Bertl, Kristina ^a   Sun, Hongchen ^c   Liu, Zhong Hao ^b   Andrukhov, Oleh ^a   Rausch Fan, Xiaohui ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b BINZHOU MEDICAL UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Alkaline phosphatase; Osteoprotegerin; Periodontium; RANK ligand; Simvastatin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALKALINE PHOSPHATASE; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SIMVASTATIN;

ADULT; ALVEOLAR BONE; ARTICLE; BONE DEVELOPMENT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; NORMAL HUMAN; OSTEOBLAST; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ALKALINE PHOSPHATASE; ALVEOLAR PROCESS; ANTICHOLESTEREMIC AGENTS; BONE REGENERATION; CELL SURVIVAL; CELLS, CULTURED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPROTEGERIN; PERIODONTAL LIGAMENT; RANK LIGAND; SIMVASTATIN; TIME FACTORS;

EID: 84862144360     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1007/s13577-011-0028-x     Document Type: Article

References (40)

1. Ward S, Lloyd Jones M, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess. 2007; 11: 1-160, iii-iv.
2. Ogura T, Tanaka Y, Nakata T, Namikawa T, Kataoka H, Ohtsubo Y. Simvastatin reduces insulin-like growth factor-1 signaling in differentiating C2C12 mouse myoblast cells in an HMG-CoA reductase inhibition-independent manner. J Toxicol Sci. 2007; 32: 57-67.
3. Jadhav SB, Jain GK. Statins and osteoporosis: new role for old drugs. J Pharm Pharmacol. 2006; 58: 3-18.
4. Garrett IR, Gutierrez G, Mundy GR. Statins and bone formation. Curr Pharm Des. 2001; 7: 715-36.
5. Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA. 2000; 283: 3205-10.
6. Edwards CJ, Hart DJ, Spector TD. Oral statins and increased bone-mineral density in postmenopausal women. Lancet. 2000; 355: 2218-9.
7. Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999; 286: 1946-9.
8. Maeda T, Matsunuma A, Kawane T, Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun. 2001; 280: 874-7.
9. Anbinder AL, Junqueira JC, Mancini MN, Balducci I, Rocha RF, Carvalho YR. Influence of simvastatin on bone regeneration of tibial defects and blood cholesterol level in rats. Braz Dent J. 2006; 17: 267-73.
10. Bjarnason NH, Riis BJ, Christiansen C. The effect of fluvastatin on parameters of bone remodeling. Osteoporos Int. 2001; 12: 380-4.
11. LaCroix AZ, Cauley JA, Pettinger M, et al. Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study. Ann Intern Med. 2003; 139: 97-104.
12. von Stechow D, Fish S, Yahalom D, et al. Does simvastatin stimulate bone formation in vivo? BMC Musculoskelet Disord. 2003; 4: 8.
13. Sodek J, McKee MD. Molecular and cellular biology of alveolar bone. Periodontology. 2000; 24: 99-126.
14. Beertsen W, McCulloch CA, Sodek J. The periodontal ligament: a unique, multifunctional connective tissue. Periodontology. 1997; 13: 20-40.
15. McCulloch CA, Bordin S. Role of fibroblast subpopulations in periodontal physiology and pathology. J Periodontal Res. 1991; 26: 144-54.
16. Meyer JR. The regenerative potential of the periodontal ligament. J Prosth Dent. 1986; 55: 260-5.
17. Gorustovich AA, Steimetz T, Giglio MJ, Guglielmotti MB. A histomorphometric study of alveolar bone modeling and remodeling under experimental anaemia and polycythaemia in rats. Arch Oral Biol. 2006; 51: 246-51.
18. Hasegawa T, Yoshimura Y, Kikuiri T, et al. Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells. J Periodontal Res. 2002; 37: 405-11.
19. Ozec I, Kilic E, Gumus C, Goze F. Effect of local simvastatin application on mandibular defects. J Craniofac Surg. 2007; 18: 546-50.
20. Stein D, Lee Y, Schmid MJ, et al. Local simvastatin effects on mandibular bone growth and inflammation. J Periodontol. 2005; 76: 1861-70.
21. Yazawa H, Zimmermann B, Asami Y, Bernimoulin JP. Simvastatin promotes cell metabolism, proliferation, and osteoblastic differentiation in human periodontal ligament cells. J Periodontol. 2005; 76: 295-302.
22. Qu Z, Rausch-Fan X, Wieland M, Matejka M, Schedle A. The initial attachment and subsequent behavior regulation of osteoblasts by dental implant surface modification. J Biomed Mat Res. 2007; 82: 658-68.
23. Rausch-fan X, Qu Z, Wieland M, Matejka M, Schedle A. Differentiation and cytokine synthesis of human alveolar osteoblasts compared to osteoblast-like cells (MG63) in response to titanium surfaces. Dent Mater. 2008; 24: 102-10.
24. Qu Z, Laky M, Ulm C, et al. Effect of Emdogain on proliferation and migration of different periodontal tissue-associated cells. Oral Surg Oral Med Oral Path Oral Radiol Endod. 2010; 109: 924-31.
25. Zhang Y, Schedle A, Matejka M, Rausch-Fan X, Andrukhov O. The proliferation and differentiation of osteoblasts in co-culture with human umbilical vein endothelial cells: an improved analysis using fluorescence-activated cell sorting. Cell Mol Biol Lett. 2010; 15: 517-29.
26. Mundy GR. Statins and their potential for osteoporosis. Bone. 2001; 29: 495-7.
27. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone. 2007; 40: 1581-7.
28. Lindy O, Suomalainen K, Makela M, Lindy S. Statin use is associated with fewer periodontal lesions: a retrospective study. BMC Oral Health. 2008; 8: 16.
29. Sakoda K, Yamamoto M, Negishi Y, Liao JK, Node K, Izumi Y. Simvastatin decreases IL-6 and IL-8 production in epithelial cells. J Dent Res. 2006; 85: 520-3.
30. Yamashita M, Otsuka F, Mukai T, et al. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. J Endocrinol. 2008; 196: 601-13.
31. Ruiz-Gaspa S, Nogues X, Enjuanes A, et al. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures. J Cell Biochem. 2007; 101: 1430-8.
32. Lima LL, Goncalves PF, Sallum EA, Casati MZ, Nociti FH Jr. Guided tissue regeneration may modulate gene expression in periodontal intrabony defects: a human study. J Periodontal Res. 2008; 43: 459-64.
33. Wakabayashi S, Tsutsumimoto T, Kawasaki S, Kinoshita T, Horiuchi H, Takaoka K. Involvement of phosphodiesterase isozymes in osteoblastic differentiation. J Bone Miner Res. 2002; 17: 249-56.
34. Lian JB, Stein GS. Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med. 1992; 3: 269-305.
35. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001; 142: 5050-5.
36. Wu B, Elmariah S, Kaplan FS, Cheng G, Mohler ER III. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease. Arterioscler Thromb Vasc Biol. 2005; 25: 592-7.
37. Maeda T, Matsunuma A, Kurahashi I, Yanagawa T, Yoshida H, Horiuchi N. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem. 2004; 92: 458-71.
38. Kim IS, Jeong BC, Kim OS, et al. Lactone form 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) stimulate the osteoblastic differentiation of mouse periodontal ligament cells via the ERK pathway. J Periodontal Res. 2011; 46: 204-13.
39. Kaji H, Kanatani M, Sugimoto T, Chihara K. Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures. Horm Metab Res. 2005; 37: 589-92.
40. Yang H, Feng Y, Luan Y. Determination of simvastatin in human plasma by liquid chromatography-mass spectrometry. J Chromatogr. 2003; 785: 369-75.